L'Hôtel-Dieu de Québec
Hôtel-Dieu de Québec
11 Côte du Palais
Québec, QC
Canada G1R 2J6

Dernières nouvelles

Information non disponible

55 enregistrements « 5 de 6 »

Boily G, Villeneuve JP, Lacoursiere L, Chaudhury P, Couture F, Ouellet JF, Lapointe R, Goulet S, Gervais N,

Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations

Article de revue

HPB (Oxford), 17 (1), 2015.

Résumé | Liens:

Iliuta IA, Beauregard JM, Couture F, Douville P, Mac-Way F

Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas

Article de revue

Clin Nucl Med, 40 (9), 2015.

Résumé | Liens:

Chen S, Villeneuve L, Jonker D, Couture F, Laverdiere I, Cecchin E, Innocenti F, Toffoli G, Levesque E, Guillemette C

ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients

Article de revue

Pharmacogenet Genomics, 25 (12), 2015.

Résumé | Liens:

Laverdiere I, Guillemette C, Tamouza R, Loiseau P, Peffault de Latour R, Robin M, Couture F, Filion A, Lalancette M, Tourancheau A, Charron D, Socie G, Levesque E

Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease

Article de revue

Haematologica, 100 (2), 2015.

Résumé | Liens:

Villa D, George A, Seymour JF, Toze CL, Crump M, Lee C, Buckstein R, Stewart DA, MacDonald D, Foley R, Xenocostas A, Sabloff M, Chua N, Couture F, Larouche JF, Cohen S, Savage KJ, Connors JM, Panzarella T, Carney DA, Dickinson M, Kuruvilla J

Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma

Article de revue

Biol Blood Marrow Transplant, 20 (11), 2014.

Résumé | Liens:

Levesque E, Belanger AS, Harvey M, Couture F, Jonker D, Innocenti F, Cecchin E, Toffoli G, Guillemette C

Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens

Article de revue

J Pharmacol Exp Ther, 345 (1), 2013.

Résumé | Liens:

Bormanis J, Quirt I, Chang J, Kouroukis CT, MacDonald D, Melosky B, Verma S, Couture F

Erythropoiesis-stimulating agents (ESAs): do they still have a role in chemotherapy-induced anemia (CIA)?

Article de revue

Crit Rev Oncol Hematol, 87 (2), 2013.

Résumé | Liens:

Morneau M, Foster W, Lalancette M, Van Nguyen-Huynh T, Renaud MC, Samouelian V, Letarte N, , Almanric K, Boily G, Bouchard P, Boulanger J, Cournoyer G, Couture F, Gervais N, Goulet S, Guay MP, Kavanagh M, Lemieux J, Lesperance B, Ouellet JF, Pineau G, Rajan R, Roy I, Samson B, Sideris L, Vincent F

Adjuvant treatment for endometrial cancer: literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO)

Article de revue

Gynecol Oncol, 131 (1), 2013.

Résumé | Liens:

Villa D, Crump M, Panzarella T, Savage KJ, Toze CL, Stewart DA, Macdonald DA, Buckstein R, Lee C, Alzahrani M, Rubinger M, Foley R, Xenocostas A, Sabloff M, Muccilli A, Chua N, Couture F, Larouche JF, Cohen S, Connors JM, Ambler K, Al-Tourah A, Ramadan KM, Kuruvilla J

Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group

Article de revue

J Clin Oncol, 31 (9), 2013.

Résumé | Liens:

Siu LL, Shapiro JD, Jonker DJ, Karapetis CS, Zalcberg JR, Simes J, Couture F, Moore MJ, Price TJ, Siddiqui J, Nott LM, Charpentier D, Liauw W, Sawyer MB, Jefford M, Magoski NM, Haydon A, Walters I, Ringash J, Tu D, O'Callaghan CJ

Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 Trial

Article de revue

J Clin Oncol, 31 (19), 2013.

Résumé | Liens:

55 enregistrements « 5 de 6 »
Signaler des ajouts ou des modifications

Projets actifs

  • Multi-pathway cholesterol depletion on top of FOLFIRINOX in newly diagnosed metastatic pancreatic adenocarcinoma: a feasibility and proof-of-concept study, du 2019-10-01 au 2025-03-31
Information provenant du registre des projets de recherche de l'Université Laval